Skip to main content

Patients Taking Psychiatric Meds Often Gain Weight. Scientists May Now Know Why

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 10, 2024.

By Ernie Mundell HealthDay Reporter

WEDNESDAY, Jan. 10, 2024 -- Weight gain has long been an unwanted side effect of medicines commonly used to treat psychiatric conditions such as bipolar disorder or schizophrenia.

Some patients may quit their meds to avoid piling on pounds. Or if they stick to their meds and weight gain continues, they face higher risks for diabetes and liver disease.

However, research in mice is pinpointing how this drug-linked weight gain happens in the first place -- and how to stop it.

The answer may lie in a hormone called leptin, explain researchers at the University of Texas Southwestern Medical Center in Dallas.

According to the Cleveland Clinic, leptin is a hormone that's emitted by fat cells and is involved in hunger and weight maintenance.

Prior research has shown that patients who start taking common psychiatric meds such as olanzapine (used against bipolar disorder) and risperidone (used to treat schizophrenia) typically experience an uptick in their leptin levels before a surge in weight gain.

The new study was conducted in mice. It might explain how a drug-induced rise in leptin is linked to added pounds.

“While it was historically viewed as a ‘passenger’ to obesity – meaning [leptin] levels go up as we gain weight – our data strongly suggest that it is a ‘driver’ for drug-induced obesity,” said study lead author Philipp Scherer. He's professor of internal medicine and director of the Touchstone Center for Diabetes Research at UT Southwestern.

“Weight gain affects most patients who start taking these antipsychotic drugs and is a well-established side effect of these interventions," he said in a UT Southwestern news release. "As a result, many individuals become insulin resistant and diabetic. The study implicates leptin as a key driver of these negative metabolic consequences."

Of course, studies in mice do not always pan out in humans. But the research did offer a hint as to how patients taking olanzapine or risperidone might avoid gaining weight.

Treating the mice with an antibody that neutralized leptin appeared to shortcircuit the weight gain, blood sugar issues and inflammation that otherwise came with higher leptin levels, the Texas group said.

“We are working hard to take the leptin-neutralizing antibodies that we have used here into a clinical setting to find out whether the mechanisms defined in rodents also apply to individuals who embark on an antipsychotic treatment regimen,” Scherer said.

The findings were published recently in Science Translational Medicine.

Sources

  • UT Southwestern Medical Center, news release, Jan. 9, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted January 2024

Read this next

Mediterranean Diet Cuts Women's Risk of Early Death by 23%

FRIDAY, May 31, 2024 -- Experts have long extolled the benefits of the Mediterranean diet and a new study adds to that evidence, finding it cuts the odds for an early death in...

Amsterdam's 'Psychiatric Ambulance' Could Be Advance For Those in Mental Health Crisis

FRIDAY, May 31, 2024 -- Ambulances meant for people having a mental health crisis could help folks get the care they need with less confrontation and friction, a new study...

Kids in Noisy Neighborhoods More Prone to Anxiety

WEDNESDAY, May 29, 2024 -- Children exposed to traffic and other noise in their neighborhoods may be at higher risk for anxiety, researchers conclude, while air pollution could...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.